This is unpublished

Estella E.
Whimbey
MD

Faculty
Infectious Diseases
Pinned
Academic
Professor Department of Medicine, Division of Allergy & Infectious Diseases
Professional
Associate Medical Director, UWMC
Medical Director, UW Employee Health Center
Medical Director, UWMC Infection Control

Related Links

UW Department of Medicine

Bio

Dr. Whimbey is an Associate Medical Director at UWMC, where she heads the Employee Health Center and the Infection Control Service. She has published over 80 peer reviewed articles, chapters and reviews, primarily relating to infections in immunocompromised patients with underlying HIV infection and neoplastic disease. Currently, her major areas of interest are the prevention of healthcare-associated infections among patients as well as healthcare workers, and systematic improvements in healthcare quality and employee safety. Abundant opportunities for clinical research exist with regard to occupational health as well as infection control.

Education & Training

MD, Cornell University Medical College, NY (1978)

Residency, Beth Israel Medical Center, Mount Sinai School of Medicine, NY (1980-1982)

Fellowship in Infectious Diseases, Memorial Sloan-Kettering Cancer Center, NY (1982-1986)

Honors

Phi Beta Kappa (1967)

Medical Resident of the Year, Beth Israel Med Center (1982)

UWMC Medical Staff Service Recognition Award (2008)

Certificate of Recognition for Education Excellence: Infection Control and Respiratory Protection eLearning Modules (2011)

Publications

Henderson D, Staiger T, Peterson G, Sinanan M, Angiulo C, Makarewicz V, Wild L, Whimbey E. A collaborative systems-level approach to eliminating healthcare-associated MRSA, central line- associated bloodstream infections, ventilator-associated pneumonia and respiratory virus infections. J Healthc Qual. 2012; 34(5):39-47. 
• PubMed Abstract

Ghosh S, Champlin RE, Ueno N, Anderlini P, Rolston K, Raad I, Kontoyiannis D, Jacobson K, Luna M, Tarrand J, Whimbey E. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: Combination therapy with aerosolized ribavirin and immunoglobulins. Bone Marrow Transplant. 2001; 28(3):271-5.
• PubMed Abstract

Ghosh S, Champlin RE, Englund J, Giralt SA, Rolston K, Raad I, Jacobson K, Neumann J, Ippoliti C, Malik S, Whimbey E. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: Combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant. 2000; 25(7):751-5.
• PubMed Abstract

Garcia R, Raad I, Abid-Said D, Bodey G, Champlin R, Tarrand J, Hill LA, Umphrey J, Neumann J, Englund J, Whimbey E. Nosocomial respiratory syncytial virus infections: Prevention and control in bone marrow transplant patients. Infect Control Hosp Epidemiol. 1997; 18(6):412-6.
• PubMed Abstract

Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis. 1996; 22(5):778-82. 
• PubMed Abstract

Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis. 1996; 22(5):778-82. 
• PubMed Abstract

Whimbey E, Champlin RE, Englund JA, et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant. 1995; 16(3):393-9.
• PubMed Abstract

Whimbey E, Couch RB, Englund JA, et al. Respiratory syncytial virus (RSV) pneumonia among hospitalized adult patients with leukemia. Clin Infect Dis. 1995; 21(2):376-9.
• PubMed Abstract